Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Zhonghua Yi Xue Za Zhi|June 27, 2006
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]Yi-feng He, Jia Fan, Jian Zhou, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinomaGuo-Ming Shi, Ai-Wu Ke, Jian Zhou, et al.
Chinese Medical Journal|May 19, 2005
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, ChinaJian Zhou, Jia Fan, Zhi-quan Wu, et al.
The Journal of Pathology|June 26, 2014
Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathwaysZhi Dai, Shao-Lai Zhou, Zheng-Jun Zhou, et al.
BMC Medicine|October 22, 2025
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 StudyXiao-Yong Huang, Guo-Ming Shi, Zhi-Tao Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transitionKai Zhu, Zhi Dai, Qi Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgeryXin-Rong Yang, Yang Xu, Bin Yu, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 20, 2024
The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insightsJi Feng, Jin-Lian Bin, Xi-Wen Liao, et al.
Hepatology (Baltimore, Md.)|June 2, 2025
The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in HCCBu-Gang Liang, Yi-Min Zheng, Ming-Hao Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resectionXin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
Pageof 3